Atorvastatin modulates the profile of proteins released by human atherosclerotic plaques

European Journal of Pharmacology

Volumn 562, Issue 1-2, 2007, Pages 119-129

  Durán, M Carmen ^a,b   Martín Ventura, Jose L ^a   Mohammed, Shabaz ^b   Barderas, María G ^a   Blanco Colio, Luis M ^a   Mas, Sebastián ^a   Moral, Verónica ^a   Ortega, Luis ^d   Tuñón, Jose ^a   Jensen, Ole N ^b   Vivanco, Fernando ^a,c   Egido, Jesús ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^d HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

Atherosclerosis; Proteomics; Statins

Indexed keywords

ATORVASTATIN; CATHEPSIN D; PROTEIN;

ARTICLE; ATHEROMA; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CAROTID ENDARTERECTOMY; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; PROTEOMICS; TWO DIMENSIONAL ELECTROPHORESIS;

BLOTTING, WESTERN; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CATHEPSIN D; CLUSTER ANALYSIS; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; PROTEINS; PROTEOMICS; PYRROLES; REPRODUCIBILITY OF RESULTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 33947538853     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.01.077     Document Type: Article

References (26)

1. Anderson T.J. Assessment and treatment of endothelial dysfunction in humans. J. Am. Coll. Cardiol. 34 (1999) 631-638
2. Auer J.W., Berent R., Weber T., and Eber B. Iron metabolism and development of atherosclerosis. Circulation 106 (2002) (e7; author reply e7)
3. Billiet L., Furman C., Larigauderie G., Copin C., Brand K., Fruchart J.C., and Rouis M. Extracellular human thioredoxin-1 inhibits lipopolysaccharide-induced interleukin-1beta expression in human monocyte-derived macrophages. J. Biol. Chem. 280 (2005) 40310-40318
4. Blanco-Colio L.M., Tunon J., Martin-Ventura J.L., and Egido J. Anti-inflammatory and immunomodulatory effects of statins. Kidney Int. 63 (2003) 12-23
5. Blanco-Colio L.M., Martin-Ventura J.L., Sol J.M., Diaz C., Hernandez G., and Egido J. Decreased circulating Fas ligand in patients with familial combined hyperlipidemia or carotid atherosclerosis: normalization by atorvastatin. J. Am. Coll. Cardiol. 43 (2004) 1188-1194
6. Blum H., Beier H., and Gross H.J. Improved silver staining of plant proteins, RNA and DNA in polyacrilamide gels. Electrophoresis 8 (1987) 93-99
7. Cipollone F., Fazia M., Iezzi A., Zucchelli M., Pini B., De Cesare D., Ucchino S., Spigonardo F., Bajocchi G., Bei R., Muraro R., Artese L., Piattelli A., Chiarelli F., Cuccurullo F., and Mezzetti A. Suppression of the functionally coupled cyclooxygenase-2/prostaglandin E synthase as a basis of simvastatin-dependent plaque stabilization in humans. Circulation 107 (2003) 1479-1485
8. Collins T., and Cybulsky M.I. NF-kappaB: pivotal mediator or innocent bystander in atherogenesis?. J. Clin. Invest. 107 (2001) 255-264
9. Dabiri G.A., Young C.L., Rosenbloom J., and Southwick F.S. Molecular cloning of human macrophage capping protein cDNA. A unique member of the gelsolin/villin family expressed primarily in macrophages. J. Biol. Chem. 267 (1992) 16545-16552
10. Davies M.J. Going from immutable to mutable atherosclerotic plaques. Am. J. Cardiol. 88 (2001) 2F-9F
11. Duran M.C., Mas S., Martin-Ventura J.L., Meilhac O., Michel J.B., Gallego-Delgado J., Lazaro A., Tunon J., Egido J., and Vivanco F. Proteomic analysis of human vessels: application to atherosclerotic plaques. Proteomics 3 (2003) 973-978
12. Gobom J., Nordhoff E., Mirgorodskaya E., Ekman R., and Roepstorff P. Sample purification and preparation technique based on nano-scale reversed-phase columns for the sensitive analysis of complex peptide mixtures by matrix-assisted laser desorption/ionization mass spectrometry. J. Mass Spectrom. 34 (1999) 105-116
13. Hakala J.K., Oksjoki R., Laine P., Du H., Grabowski G.A., Kovanen P.T., and Pentikainen M.O. Lysosomal enzymes are released from cultured human macrophages, hydrolyze LDL in vitro, and are present extracellularly in human atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 23 (2003) 1430-1436
14. Herrero J., Valencia A., and Dopazo J. A hierarchical unsupervised growing neural network for clustering gene expression patterns. Bioinformatics 17 (2001) 126-136
15. Herrero J., Al-Shahrour F., Diaz-Uriarte R., Mateos A., Vaquerizas J.M., Santoyo J., and Dopazo J. GEPAS: a web-based resource for microarray gene expression data analysis. Nucleic Acids Res. 31 (2003) 3461-3467
16. Higuchi T., Watanabe Y., and Waga I. Protein disulfide isomerase suppresses the transcriptional activity of NF-kappaB. Biochem. Biophys. Res. Commun. 318 (2004) 46-52
17. Kaesberg B., Harrach B., Dieplinger H., and Robenek H. In situ immunolocalization of lipoproteins in human arteriosclerotic tissue. Arterioscler. Thromb. 13 (1993) 133-146
18. Kolodgie F.D., Narula J., Burke A.P., Haider N., Farb A., Hui-Liang Y., Smialek J., and Virmani R. Localization of apoptotic macrophages at the site of plaque rupture in sudden coronary death. Am. J. Pathol. 157 (2000) 1259-1268
19. Li W., and Yuan X.M. Increased expression and translocation of lysosomal cathepsins contribute to macrophage apoptosis in atherogenesis. Ann. N. Y. Acad. Sci. 1030 (2004) 427-433
20. Li W., Dalen H., Eaton J.W., and Yuan X.M. Apoptotic death of inflammatory cells in human atheroma. Arterioscler. Thromb. Vasc. Biol. 21 (2001) 1124-1130
21. Licklider L.J., Thoreen C.C., Peng J., and Gygi S.P. Automation of nanoscale microcapillary liquid chromatography-tandem mass spectrometry with a vented column. Anal. Chem. 74 (2002) 3076-3083
22. Martin-Ventura J.L., Duran M.C., Blanco-Colio L.M., Meilhac O., Leclercq A., Michel J.B., Jensen O.N., Hernandez-Merida S., Tunon J., Vivanco F., and Egido J. Identification by a differential proteomic approach of heat shock protein 27 as a potential marker of atherosclerosis. Circulation 110 (2004) 2216-2219
23. Martin-Ventura J.L., Blanco-Colio L.M., Gomez-Hernandez A., Munoz-Garcia B., Vega M., Serrano J., Ortega L., Hernandez G., Tunon J., and Egido J. Intensive treatment with atorvastatin reduces inflammation in mononuclear cells and human atherosclerotic lesions in one month. Stroke 36 (2005) 1796-1800
24. Shevchenko A., Wilm M., Vorm O., and Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68 (1996) 850-858
25. Vivanco F., Martin-Ventura J.L., Duran M.C., Barderas M.G., Blanco-Colio L., Darde V.M., Mas S., Meilhac O., Michel J.B., Tunon J., and Egido J. Quest for novel cardiovascular biomarkers by proteomic analysis. J. Proteome Res. 4 (2005) 1181-1191
26. Walldius G., and Jungner I. Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy. J. Intern. Med. 255 (2004) 188-205